Trump Tries To Shame A Defiant Pfizer On Drug Pricing
President Trump called out Pfizer’s recent price increases on Twitter July 9. Pfizer was one of only four companies that took a second round of price increases in 2018, according to analysts at Morgan Stanley. CEO Read has long defended the industry's pricing practices, even as public criticism of the high drug prices has grown.
You may also be interested in...
As then-Novartis CEO Joe Jimenez worked with former Trump lawyer Michael Cohen on drug pricing issues, the pharma industry was preparing for the debate it's eventually getting to have.
Look for Administration to take credit for any positive pricing news as President says several firms will 'announce voluntary massive drops in prices.'
The reform 'blueprint' might actually live up to its hype.